Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Diagnostic Microbiology and Infectious Disease|March 1, 2011
In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococciDavid J Farrell, Kevin M Krause, Bret M Benton
Antimicrobial Agents and Chemotherapy|March 14, 2012
Further insights into the mode of action of the lipoglycopeptide telavancin through global gene expression studiesYang Song, Christopher S Lunde, Bret M Benton, et al.
Microbial Drug Resistance (Larchmont, N.Y.)|April 5, 2013
Studies on the mechanism of telavancin decreased susceptibility in a laboratory-derived mutantYang Song, Christopher S Lunde, Bret M Benton, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
Antistaphylococcal activity of TD-1792, a multivalent glycopeptide-cephalosporin antibioticJohanne Blais, Stacey R Lewis, Kevin M Krause, et al.
Diagnostic Microbiology and Infectious Disease|September 18, 2010
In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studiesKevin M Krause, Steven L Barriere, Michael M Kitt, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2010
Fluorescence microscopy demonstrates enhanced targeting of telavancin to the division septum of Staphylococcus aureusChristopher S Lunde, Charles H Rexer, Stephanie R Hartouni, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United StatesDeborah C Draghi, Bret M Benton, Kevin M Krause, et al.
The Journal of Antimicrobial Chemotherapy|February 9, 2010
Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemiaSharath S Hegde, Robert Skinner, Stacey R Lewis, et al.
Antimicrobial Agents and Chemotherapy|April 30, 2008
In vitro activity of telavancin against resistant gram-positive bacteriaKevin M Krause, Marika Renelli, Stacey Difuntorum, et al.
The Journal of Antimicrobial Chemotherapy|April 22, 2008
In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance InitiativeDeborah C Draghi, Bret M Benton, Kevin M Krause, et al.
Pageof 3